Pharmaceutical glass manufacturer Stevanato Group is to expand its headquarters.
It said the expansion of its headquarters in Piombino Dese, Italy would advance operations and growth of the company.
The new 6,750m2 facility is expected to support the optimisation of its industrial footprint, with about 2,500m2 dedicated to increasing the production of high-value products.
In addition to hosting offices, the Italian analytical services site, and R&D space, it is also expected to include new glass syringe forming lines devoted to boosting the production of EZ-fill solutions, which are pre-sterilised drug containment solutions that reduce total cost of ownership and time-to-market for pharmaceutical companies.
Franco Moro, CEO of Stevanato Group. “Further increasing our production capabilities here at home through this new space we expect to be able to bridge capacity demands while our exciting projects in the US and China are underway."
Construction of the new building began in September 2021.
The company expects to install and validate new lines in the second quarter of 2022, and expects industrial production to begin between late second quarter and early third quarter of 2022.